{"name":"Mingzhi Zhang","slug":"mingzhi-zhang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"PD-1 Antibody, chidamide, lenalidomide and etoposide","genericName":"PD-1 Antibody, chidamide, lenalidomide and etoposide","slug":"pd-1-antibody-chidamide-lenalidomide-and-etoposide","indication":"Other","status":"marketed"},{"name":"Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）","genericName":"Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）","slug":"modified-smile-mtx-dex-ifo-l-asp-etoposide-mesna","indication":"Other","status":"marketed"},{"name":"Yangzhengxiaoji capsule combined with CHOP regimen","genericName":"Yangzhengxiaoji capsule combined with CHOP regimen","slug":"yangzhengxiaoji-capsule-combined-with-chop-regimen","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"PD-1 Antibody, chidamide, lenalidomide and etoposide","genericName":"PD-1 Antibody, chidamide, lenalidomide and etoposide","slug":"pd-1-antibody-chidamide-lenalidomide-and-etoposide","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）","genericName":"Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）","slug":"modified-smile-mtx-dex-ifo-l-asp-etoposide-mesna","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Yangzhengxiaoji capsule combined with CHOP regimen","genericName":"Yangzhengxiaoji capsule combined with CHOP regimen","slug":"yangzhengxiaoji-capsule-combined-with-chop-regimen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE96QmEwbE8wN2MtOFptLWM1VnZ6UHh2eEV0Q2QyczB6Uy1oTjBrN01PNTZYdEJONW5zLTV2Q0JEcGZRNW1Od3ZaOXFqVS1WeXdHWFhlSXlHbmcyamE3ajVn?oc=5","date":"2024-08-20","type":"pipeline","source":"Nature","summary":"LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma - Nature","headline":"LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBjN2RwUWxRQUhsTnEtNEtET1ZLVW9nSG9PX3ZlOURhUzZTbWZXQ2JycFV6Unk5RHZCV1lfZ2JQZmdGb0hzOEotLUswd1VwTVFYSGlnRHk2Si1PRWh0bzN0Zkx1aUVFQ1k1RnhWYWRB?oc=5","date":"2023-05-30","type":"pipeline","source":"ahajournals.org","summary":"Spatial Multiplexed Protein Profiling of Cardiac Ischemia-Reperfusion Injury | Circulation Research - ahajournals.org","headline":"Spatial Multiplexed Protein Profiling of Cardiac Ischemia-Reperfusion Injury | Circulation Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBkcFIySFFVVWxYaWJUZ3NhYWxLMXI3ZW1SWFk2bE9JRkJPTW1WOG05VEsyZktaQUpmN3hJTDM4VS1nSmU3NUFFcFMwYllXanZiclFPTDlnOG9feXRoZ3A5UE11UHJEV1U?oc=5","date":"2023-05-23","type":"pipeline","source":"Wiley Online Library","summary":"Innovative advancement of contact lenses for noninvasive diagnosis and therapy: A mini review - Wiley Online Library","headline":"Innovative advancement of contact lenses for noninvasive diagnosis and therapy: A mini review","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}